AKT1 and lung carcinoma: The aberrant activation of the nonreceptor tyrosine kinase Src-associated signaling pathways, such as PI3K/AKT and MEK/ERK signals, have been emerging as a determinant of multiple resistance occurrence in lung cancer cells.